Clinicians’ guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease

BACKGROUND: Objective monitoring of the severity of inflammation in patients with inflammatory bowel disease (IBD) is an essential part of disease management. However, repeat endoscopy to define extent and severity of inflammation is not practical. Fecal calprotectin (FC) is a biomarker that can be...

Full description

Saved in:
Bibliographic Details
Published in:Can J Gastroenterol Hepatol
Main Authors: Bressler, Brian, Panaccione, Remo, Fedorak, Richard N, Seidman, Ernest G
Format: Artigo
Language:Inglês
Published: Pulsus Group Inc 2015
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4610647/
https://ncbi.nlm.nih.gov/pubmed/26125109
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items